Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study

被引：2

作者：

Ahn, Myung-Ju ^{[1
]}

Lim, Sung Hee ^{[1
]}

Sun, Jong -Mu ^{[1
]}

Choi, Yoon-La ^{[1
]}

Kim, Hye Ryun ^{[2
]}

Ahn, Soo-min ^{[1
]}

Lee, Se-Hoon ^{[1
]}

Ahn, Jin Seok ^{[1
]}

Park, Keunchil ^{[1
]}

Kim, Joo Hang ^{[2
]}

Cho, Byoung Chul ^{[2
]}

机构：

[1] Samsung Med Ctr, Seoul, South Korea

[2] Yunsei Univ, Seoul, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 02期

关键词：

D O I：

10.1016/j.jtho.2015.12.027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S16 / S16

页数：1

共 50 条

[41] FGFR1 amplification and EGFR mutation in Chinese squamous cell lung cancer. [J].

Wei, Zhigang ;

Wang, Jie ;

Bai, Hua ;

An, Tongtong ;

Wang, Zhijie ;

Zhuo, Minglei ;

Wu, Meina ;

Yang, Lu .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[42] Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial [J].

Gao, Ming ;

Zhang, Xia ;

Yan, Huan ;

Zhao, Yan ;

Yuan, Fang ;

Sun, Decong ;

Yang, Xuejiao ;

Ju, Yanfang ;

Wang, Lijie ;

Tao, Haitao ;

Tian, Luyuan ;

Zhao, Changhong ;

Ma, Junxun ;

Hu, Yi ;

Liu, Zhefeng .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17

[43] Anlotinib in elderly patients with advanced non-squamous non-small cell lung cancer (NSCLC) who had not received systemic chemotherapy: A single-arm, multi-center, phase II study [J].

Zhao, D. ;

Hou, X. ;

Li, Z. ;

Yang, L. ;

Hou, X. ;

Li, H. ;

Yan, L. ;

Liu, H. ;

Li, Z. ;

Liu, X. ;

Song, F. ;

Li, G. ;

Zhang, Y. .

ANNALS OF ONCOLOGY, 2021, 32 :S1022-S1022

[44] Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC). [J].

Stani, SC ;

Carillio, G ;

Meo, S ;

Morabito, A ;

Bonginelli, P ;

Comella, G ;

Mansueto, G ;

Avallone, A ;

Gion, M ;

Gasparini, G .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :700S-700S

[45] Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study [J].

Lu, Shun ;

Zhou, Jian-Ying ;

Niu, Xiao-Min ;

Zhou, Jian-Ya ;

Jian, Hong ;

Yin, Hong-Yan ;

Guan, Sha ;

Wang, Lin-Fang ;

Li, Ke ;

He, James ;

Su, Wei-Guo .

TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) :839-+

[46] Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial [J].

Chaft, Jamie E. ;

Oezkan, Filiz ;

Kris, Mark G. ;

Bunn, Paul A. ;

Wistuba, Ignacio I. ;

Kwiatkowski, David J. ;

Owen, Dwight H. ;

Tang, Yan ;

Johnson, Bruce E. ;

Lee, Jay M. ;

Lozanski, Gerard ;

Pietrzak, Maciej ;

Seweryn, Michal ;

Byun, Woo Yul ;

Schulze, Katja ;

Nicholas, Alan ;

Johnson, Ann ;

Grindheim, Jessica ;

Hilz, Stephanie ;

Shames, David S. ;

Rivard, Chris ;

Toloza, Eric ;

Haura, Eric B. ;

McNamee, Ciaran J. ;

Patterson, G. Alexander ;

Waqar, Saiama N. ;

Rusch, Valerie W. ;

Carbone, David P. .

NATURE MEDICINE, 2022, 28 (10) :2155-+

[47] Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial [J].

Jamie E. Chaft ;

Filiz Oezkan ;

Mark G. Kris ;

Paul A. Bunn ;

Ignacio I. Wistuba ;

David J. Kwiatkowski ;

Dwight H. Owen ;

Yan Tang ;

Bruce E. Johnson ;

Jay M. Lee ;

Gerard Lozanski ;

Maciej Pietrzak ;

Michal Seweryn ;

Woo Yul Byun ;

Katja Schulze ;

Alan Nicholas ;

Ann Johnson ;

Jessica Grindheim ;

Stephanie Hilz ;

David S. Shames ;

Chris Rivard ;

Eric Toloza ;

Eric B. Haura ;

Ciaran J. McNamee ;

G. Alexander Patterson ;

Saiama N. Waqar ;

Valerie W. Rusch ;

David P. Carbone .

Nature Medicine, 2022, 28 :2155-2161

[48] FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response [J].

Bogatyrova, Olga ;

Mattsson, Johanna S. M. ;

Ross, Edith M. ;

Sanderson, Michael P. ;

Backman, Max ;

Botling, Johan ;

Brunnstrom, Hans ;

Kurppa, Pinja ;

La Fleur, Linnea ;

Strell, Carina ;

Wilm, Claudia ;

Zimmermann, Astrid ;

Esdar, Christina ;

Micke, Patrick .

EUROPEAN JOURNAL OF CANCER, 2021, 151 :136-149

[49] Single-arm, phase II study of pyrotinib in advanced non-small cell lung cancer (NSCLC) patients with HER2 exon 20 mutation. [J].

Gao, Guanghui ;

Li, Xingya ;

Wang, Qiming ;

Zhang, Yiping ;

Chen, Jianhua ;

Shu, Yongqian ;

Hu, Yanping ;

Fan, Yun ;

Fang, Jian ;

Chen, Gongyan ;

Zhao, Jun ;

He, Jianxing ;

Wu, Fengying ;

Zou, Jianjun ;

Zhu, Xiaoyu ;

Zhou, Caicun .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[50] Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study [J].

Stathopoulos, G. P. ;

Trafalis, D. ;

Dimitroulis, J. ;

Athanasiou, A. ;

Koutantos, J. ;

Anagnostopoulos, A. .

ONCOLOGY LETTERS, 2010, 1 (02) :335-338

← 1 2 3 4 5 →